DNABW (Ginkgo Bioworks Holdings) FCF Yield %: -3,580,900.00 (As of Jun. 25, 2026)


DNABW Ginkgo Bioworks Holdings Inc DNABW
63 GF Score
Price $0.00
! 5 Warning Signs
View Full Analysis

What is Ginkgo Bioworks Holdings FCF Yield %?

Ginkgo Bioworks Holdings DNABW -18.18% 63 FCF Yield % is -3,580,900.00 as of Jun. 25, 2026. GuruFocus rates DNABW with a GF Score™ of 63/100. The stock has 5 warning signs investors should review. Among 1,418 Biotechnology companies, Ginkgo Bioworks Holdings ranks worse than 71.72% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ginkgo Bioworks Holdings's Trailing 12-Month Free Cash Flow is $0.00 Mil, and Market Cap is $0.00 Mil. Therefore, Ginkgo Bioworks Holdings's FCF Yield % for today is -3,580,900.00%.

The historical rank and industry rank for Ginkgo Bioworks Holdings's FCF Yield % or its related term are showing as below:

DNABW' s FCF Yield % Range Over the Past 10 Years
Min: -3580900   Med: -15.48   Max: -1.18
Current: -3580900


During the past 7 years, the highest FCF Yield % of Ginkgo Bioworks Holdings was -1.18%. The lowest was -3580900.00%. And the median was -15.48%.

DNABW's FCF Yield % is ranked worse than
71.72% of 1418 companies
in the Biotechnology industry
Industry Median: -9.64 vs DNABW: -3580900.00

Ginkgo Bioworks Holdings's FCF Margin % for the quarter that ended in Mar. 2026 was -249.66%.


Ginkgo Bioworks Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Ginkgo Bioworks Holdings FCF Yield % Related Terms


Ginkgo Bioworks Holdings FCF Yield % Historical Data

* Premium members only.

The historical data trend for Ginkgo Bioworks Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ginkgo Bioworks Holdings FCF Yield % Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Ginkgo Bioworks Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DNABW vs CADL, CABA, CLYM: FCF Yield % Comparison

For the Biotechnology subindustry, Ginkgo Bioworks Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ginkgo Bioworks Holdings FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ginkgo Bioworks Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ginkgo Bioworks Holdings's FCF Yield % falls into.


DNABW
63GF Score
Ginkgo Bioworks Holdings Inc DNABW
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ginkgo Bioworks Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ginkgo Bioworks Holdings's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-178.724 /
=N/A%

Ginkgo Bioworks Holdings's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-48.619 * 4 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -3,580,900.00 mean?
Ginkgo Bioworks Holdings (DNABW) has a FCF Yield % of -3,580,900.00 as of Jun. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ginkgo Bioworks Holdings and its competitors. According to the industry distribution chart, Ginkgo Bioworks Holdings ranks #1017 out of 1418 companies in the Biotechnology industry, placing it in the top 71.7%.
Is Ginkgo Bioworks Holdings' FCF Yield % too high?
Ginkgo Bioworks Holdings' current FCF Yield % is -3,580,900.00. Based on the distribution chart, Ginkgo Bioworks Holdings ranks #1017 out of 1418 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' FCF Yield % compare to CADL and CABA?
According to the Biotechnology industry distribution chart, Ginkgo Bioworks Holdings ranks #1017 out of 1418 companies for FCF Yield %. This places Ginkgo Bioworks Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ginkgo Bioworks Holdings and its competitors. Ginkgo Bioworks Holdings's current FCF Yield % is -3,580,900.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Ginkgo Bioworks Holdings (DNABW) has a current FCF Yield % of -3,580,900.00. The current FCF Yield % is -3,580,900.00. Ginkgo Bioworks Holdings' overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (DNABW), the current FCF Yield % is -3,580,900.00 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ginkgo Bioworks Holdings Business Description

Other Exchanges DNA:USADNA:Mexico
Address 27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
63GF Score

Get the complete analysis for DNABW

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price